Erythropoietin Stimulates Cancer Cell Migration and Activates RhoA Protein through a Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase-Dependent Mechanism

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.107.129643PMID 18079357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.

  2007cited by this paper
• Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity

  2006cited by this paper
• Erythropoietin Receptor Signal Transduction Requires Protein Geranylgeranylation

  2006cited by this paper
• Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex.

  2006cited by this paper
• Regulation of Rho proteins by phosphorylation in the cardiovascular system.

  2006cited by this paper
• RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.

  2006cited by this paper
• Erythropoietin Promotes MCF-7 Breast Cancer Cell Migration by an ERK/Mitogen-activated Protein Kinase-dependent Pathway and Is Primarily Responsible for the Increase in Migration Observed in Hypoxia*

  2005influential reference
• Vav-family proteins in T-cell signalling.

  2005cited by this paper
• GAPs in growth factor signalling

  2005cited by this paper
• Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.

  2005cited by this paper
• Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma

  2005influential reference
• Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia.

  2005cited by this paper
• Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin.

  2004cited by this paper
• The erythropoietin-receptor pathway modulates survival of cancer cells

  2004cited by this paper
• Erythropoietin receptor expression in biopsy specimens from patients with uterine cervix squamous cell carcinoma

  2004influential reference
• ERK and RhoA Differentially Regulate Pseudopodia Growth and Retraction during Chemotaxis*

  2003cited by this paper
• Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.

  2003cited by this paper
• Erythropoietin regulates tumour growth of human malignancies.

  2003cited by this paper
• Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma

  2002cited by this paper
• Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway

  2002influential reference
• Functional Significance of Erythropoietin Receptor Expression in Breast Cancer

  2002cited by this paper
• Cooperativity between the Ras-ERK and Rho-Rho Kinase Pathways in Urokinase-type Plasminogen Activator-stimulated Cell Migration*

  2002cited by this paper
• Erythropoietin and erythropoietin receptor expression in human cancer.

  2001cited by this paper
• Rap1 Is Activated by Erythropoietin or Interleukin-3 and Is Involved in Regulation of β1 Integrin-mediated Hematopoietic Cell Adhesion*

  2001influential reference
• Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells

  2001cited by this paper
• Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

  2000cited by this paper
• Scar/WAVE‐1, a Wiskott–Aldrich syndrome protein, assembles an actin‐associated multi‐kinase scaffold

  2000cited by this paper
• Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells.

  1999cited by this paper
• Myosin Light Chain Kinase Functions Downstream of Ras/ERK to Promote Migration of Urokinase-Type Plasminogen Activator-Stimulated Cells in an Integrin-Selective Manner

  1999cited by this paper
• Mitogen-activated protein kinase activation mediates PDGF-directed migration of RPE cells.

  1998cited by this paper
• Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility*

  1998cited by this paper
• A Distinct Function of STAT Proteins in Erythropoietin Signal Transduction*

  1997cited by this paper
• Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells.

  1997cited by this paper
• Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)*

  1996cited by this paper
• Phosphorylation of Tyrosine 503 in the Erythropoietin Receptor (EpR) Is Essential for Binding the P85 Subunit of Phosphatidylinositol (PI) 3-Kinase and for EpR-associated PI 3-Kinase Activity (*)

  1995cited by this paper
• PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*)

  1995cited by this paper
• Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility.

  1994influential reference
• JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.

  1993cited by this paper
• Erythropoietin induces p21ras activation and p120GAP tyrosine phosphorylation in human erythroleukemia cells.

  1992influential reference
• Erythropoietin receptor and interleukin-2 receptor beta chain: a new receptor family.

  1989cited by this paper
• Erythropoietin receptor and interleukin-2 receptor β chain: A new receptor family

  1989cited by this paper
• DEPARTMENT OF INTERNAL MEDICINE

  1966cited by this paper

• Biomolecules‐releasing click chemistry‐based bioadhesives for repairing acetabular labrum tears

  2022cites this paper
• The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization

  2021cites this paper
• Erythropoietin, Stem Cell Factor, and Cancer Cell Migration.

  2017cites this paper
• BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity

  2015cites this paper
• Overexpression of RhoA promotes the proliferation and migration of cervical cancer cells

  2014cites this paper
• Systematic Review: The Association and Impact of Financial Conflicts of Interest in Basic Science Research

  2014cites this paper
• Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.

  2014cites this paper
• Early Activation of MAP Kinases by Influenza A Virus X-31 in Murine Macrophage Cell Lines

  2014cites this paper
• A new mechanism of RhoA ubiquitination and degradation: roles of SCF(FBXL19) E3 ligase and Erk2.

  2013cites this paper
• ROCKing the JAKs

  2013cites this paper
• Signal Transduction Effects Induced by Erythropoietin in a HNSCC Model System

  2012cites this paper
• The effect of erythropoietin on normal and neoplastic cells

  2012cites this paper
• Erythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation

  2012cites this paper
• Autocrine/paracrine erythropoietin signalling promotes JAK/STAT‐dependent proliferation of human cervical cancer cells

  2011cites this paper
• Erythropoietin Increases Expression and Function of Transient Receptor Potential Canonical 5 Channels

  2011cites this paper
• Randomized controlled trials of the erythroid-stimulating agents in cancer patients.

  2011cites this paper
• Transduction of human EPO into human bone marrow mesenchymal stromal cells synergistically enhances cell-protective and migratory effects

  2010cites this paper
• Role of erythropoietin receptor expression in malignant melanoma.

  2010cites this paper
• Erythropoietin-Induced Activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK Pathways Promotes Malignant Cell Behavior in a Modified Breast Cancer Cell Line

  2010cites this paper
• Rho Proteins in Cancer

  2010cites this paper
• Anti-glycophorin single-chain Fv fusion to low-affinity mutant erythropoietin improves red blood cell-lineage specificity.

  2010cites this paper
• Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents.

  2010cites this paper
• Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2.

  2009cites this paper
• Biological functions and therapeutic use of erythropoiesis‐stimulating agents: perplexities and perspectives

  2009cites this paper
• Anaemia: a rare but neglected problem among Finnish patients receiving chemotherapy for solid tumours

  2009cites this paper
• Anemia management in oncology and hematology.

  2009cites this paper
• The Role of Erythropoietin as an Inhibitor of Tissue Ischemia

  2008cites this paper